2022/12/19 / Erste Group Research |
ATX: Attraktiv bewertet ins Jahr 2023 Der ATX dürfte das ereignisreiche 2022 mit einem Minus von rund 20% abschließen. Die Kernthemen Ukraine-Krieg, Energie, Inflations- und Zinsanstieg spiegelten sich dabei stark in der Aktien-Performance wider. SBO und DO&CO führen die ATX-Kursliste an, ans untere Ende fielen Lenzing und Immofinanz. Bewertungstechnisch startet der ATX auf 10-Jahres-Tiefständen ins Jahr 2023 bei gleichzeitig hoher Rentabilität und Dividendenrendite. |
![]() |
Author | Erste Group Research |
Date | 2022/12/19 |
Language | ![]() |
Product name | Empfehlungsliste |
Topic in focus | Equities |
Economy in focus | Austria |
Currency in focus | Euro |
Sector in focus | Automobiles & Parts, Banks, Basic Resources, Chemicals, Construction & Material, Food & Beverage, Health Care, Industrial Goods & Services, Insurance, Oil & Gas, Real Estate, Technology, Telecommunications, Travel & Leisure, Utilities |
Download |
Name | ISIN | # Erste Group products |
Addiko Bank | AT000ADDIKO0 | 0 |
Agrana | AT000AGRANA3 | 0 |
AMAG | AT00000AMAG3 | 0 |
ams OSRAM | AT0000A18XM4 | 0 |
Andritz | AT0000730007 | 0 |
AT&S | AT0000969985 | 0 |
Austrian Post | AT0000APOST4 | 0 |
BAWAG | AT0000BAWAG2 | 0 |
CA IMMO | AT0000641352 | 0 |
DO & CO | AT0000818802 | 0 |
FACC | AT00000FACC2 | 0 |
Immofinanz | AT0000A21KS2 | 0 |
Kapsch TrafficCom | AT000KAPSCH9 | 0 |
Lenzing | AT0000644505 | 0 |
Marinomed Biotech AG | ATMARINOMED6 | 0 |
Mayr-Melnhof | AT0000938204 | 0 |
OMV | AT0000743059 | 2 |
Palfinger | AT0000758305 | 0 |
Polytec | AT0000A00XX9 | 0 |
PORR | AT0000609607 | 0 |
RBI | AT0000606306 | 3 |
S Immo | AT0000652250 | 0 |
SBO | AT0000946652 | 0 |
Semperit | AT0000785555 | 0 |
STRABAG | AT000000STR1 | 0 |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer